Search

Kuduwave™ testing aboard the ISS

What does it take to make an audiometer and tympanometry ready for the space age? In a recent interview, Jillian Scotland and Dirk Koekemoer shared their first-hand experience of getting the Kuduwave ready for a voyage to the ISS. It...

COOL therapy for cisplatin-induced hearing loss

Cisplatin is a commonly used cancer therapy, with nearly 50% of patients undergoing chemotherapy receiving cisplatin as part of their regimen [1]. Depending on the dose, incidence of hearing loss has been reported as 12-100% in adults, and 37-94% in...

Innovations in remote/teleaudiology patient care

Audiometry remains the gold standard in hearing evaluations. Changes in the delivery of audiometry remain a key challenge in providing a telehealth approach to hearing care. The team at Lyon University Hospital validated an innovative approach to solving this challenge,...

Platinum-based chemotherapy, tinnitus and hearing loss

Fortunately, the five-year survival rate of adult cancers is increasing. However, we are seeing for the first time the lasting effects of cancer treatments on people. As more people live with the long-term effects of treatment, such as chemotherapy, it is imperative to understand the impact it has on quality of life.

The importance of s-ABR in auditory disorders

S-ABR is a method of recording speech-evoked-potentials, but where does it fit in the clinical and research test battery? Here, the authors examine the opportunities for s-ABR. The integrity of the neural transmission of acoustic stimuli is evaluated by auditory...

Aligning hearing and cognitive healthcare in older people

Published in print under the titleHearing care and dementia: professional insights on the new Lancet Commission findingsThe Lancet Commission on ‘Dementia prevention, intervention and care: 2024 report’ highlights a list of potential modifiable factors to reduce dementia risk. As with...